Ablation therapy is the widely accepted definitive therapy for atrioventricular reentry tachycardia. Noninducibility of the tachycardia is the targeted end point of the procedure. We report on 21 patients with documented narrow QRS tachycardia, in whom the clinical tachycardia could not be induced during the electrophysiologic study.
View Article and Find Full Text PDF